By: Sara Riascos  Apr. 11, 2022

Major Joint Replacement is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Eliquis (Apixaban) is an anticoagulant prescribed by doctors to reduce the risk of stroke caused by blood clots. Studies have shown that the early use of Eliquis (Apixaban) after a Major joint replacement surgery is associated with lower rates of clinically relevant bleeding. Other studies have shown that Eliquis reduces the risk of blood clots forming in lungs and legs after undergoing a Major Joint Replacement surgery.